Suppr超能文献

肝素-鱼精蛋白不匹配。心脏直视手术后出血的一个可控因素。

Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery.

作者信息

DeLaria G A, Tyner J J, Hayes C L, Armstrong B W

机构信息

Division of Cardiac Surgery, Scripps Clinic, La Jolla, Calif.

出版信息

Arch Surg. 1994 Sep;129(9):944-50; discussion 950-1. doi: 10.1001/archsurg.1994.01420330059012.

Abstract

OBJECTIVE

To test the effect of a new system designed to reduce heparin-protamine mismatch on bleeding after open heart surgery.

DESIGN

Nonrandomized but consecutive retrospective review of patients undergoing open heart surgery during a 9-month period.

SETTING

Multispecialty referral center.

PATIENTS

A total of 150 patients comparable by age, body surface area, and coagulation status undergoing primary open heart surgery for either coronary bypass or heart valve replacement.

INTERVENTION

In the first 75 patients (group 1), heparin sodium was neutralized with protamine sulfate, using a fixed ratio (1 mg of heparin sodium to 1.3 mg of protamine sulfate). An activated clotting time was used to confirm heparin neutralization. For the subsequent 75 patients (group 2), titration of heparin and protamine from defined lots was accomplished using activated clotting times adjusted and matched to drug lots to minimize biologic variability. Groups 1 and 2 had comparable operations, pump times, and cross-clamp times.

MAIN OUTCOME MEASURES

Doses of heparin and protamine and their effect on blood product transfusion and postoperative bleeding were evaluated in all patients.

RESULTS

The average protamine sulfate dose for group 2 patients (287.56 +/- 8.3 mg) was significantly lower than that for group 1 (346.01 +/- 12.6 mg) (P < .0005). Less protamine was associated with the transfusion of fewer red blood cells (0.92 +/- 0.15 vs 2.57 +/- 0.38 U) (P < .001), platelets (0.72 +/- 0.8 vs 2.96 +/- 0.80 U) (P < .01), and fresh-frozen plasma (0.83 +/- 2.0 vs 2.01 +/- 0.48 U) (P < .03). No patients in group 2 required reexploration for bleeding, compared with eight patients in group 1.

CONCLUSIONS

A reduction in protamine dose was associated with significant decreases in blood product use and postoperative bleeding. Excess protamine warrants consideration as both an important and a controllable factor in coagulopathy after open heart surgery.

摘要

目的

测试一种旨在减少肝素-鱼精蛋白不匹配的新系统对心脏直视手术后出血的影响。

设计

对9个月期间接受心脏直视手术的患者进行非随机但连续的回顾性研究。

地点

多专科转诊中心。

患者

总共150例年龄、体表面积和凝血状态相当的患者,接受冠状动脉搭桥或心脏瓣膜置换的初次心脏直视手术。

干预措施

在前75例患者(第1组)中,使用固定比例(1毫克肝素钠对应1.3毫克硫酸鱼精蛋白)用硫酸鱼精蛋白中和肝素钠。采用活化凝血时间来确认肝素已被中和。对于随后的75例患者(第2组),使用根据药物批次调整并匹配的活化凝血时间来滴定来自特定批次的肝素和鱼精蛋白,以尽量减少生物变异性。第1组和第2组的手术、体外循环时间和主动脉阻断时间相当。

主要观察指标

评估所有患者的肝素和鱼精蛋白剂量及其对血液制品输注和术后出血的影响。

结果

第2组患者的硫酸鱼精蛋白平均剂量(287.56±8.3毫克)显著低于第1组(346.01±12.6毫克)(P<.0005)。较少的鱼精蛋白与较少的红细胞输注量(0.92±0.15单位对2.57±0.38单位)(P<.001)、血小板输注量(0.72±0.08单位对2.96±0.80单位)(P<.01)和新鲜冰冻血浆输注量(0.83±2.0单位对2.01±0.48单位)(P<.03)相关。第2组没有患者因出血需要再次手术探查,而第1组有8例患者需要。

结论

鱼精蛋白剂量的减少与血液制品使用量和术后出血的显著减少相关。过量的鱼精蛋白应被视为心脏直视手术后凝血障碍的一个重要且可控因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验